Form 4: Viridian Therapeutics, Inc.\DE Executive Sells Shares
Insider Transaction (Form 4)
Jennifer Tousignant, Chief Legal Officer of Viridian Therapeutics, Inc.\DE, sold 14,212 shares of common stock on August 19, 2026 for $24.50 per share.
Summary
- Open-market sale: disposed of 4,212 Common Stock at $24.50 ($103,194) on August 19, 2026 (Direct).
- Option exercise/conversion: acquired 10,000 Common Stock at $14.41 ($144,100) on August 19, 2026; holds 10,000 after (Direct).
- Open-market sale: disposed of 10,000 Common Stock at $24.50 ($245,000) on August 19, 2026 (Direct).
- Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on August 19, 2026; holds 114,072 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $348,194 of stock on the open market.
Insider Transactions
Jennifer Tousignant — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Open-market sale | Common Stock | 4,212 | $25 | $103.2K | 0 |
| 2026-08-19 | Option exercise/conversion | Common Stock | 10,000 | $14 | $144.1K | 10,000 |
| 2026-08-19 | Open-market sale | Common Stock | 10,000 | $25 | $245.0K | 0 |
| 2026-08-19 | Option exercise/conversion | Stock Option (Right to Buy) | 10,000 | — | — | 114,072 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Open-market sale (4,212 shares) |
| 2026-08-19 | Option exercise/conversion (10,000 shares) |
| 2026-08-19 | Open-market sale (10,000 shares) |
| 2026-08-19 | Option exercise/conversion (10,000 shares) |
Keywords
insider transaction, Form 4, VRDN, Viridian Therapeutics, Inc.\DE, bearish, Jennifer Tousignant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.